Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Leapmotor (零跑汽车) T03 Sweeps Germany with €49 Monthly Lease: Achieving "Phone Bill-Level" Car Ownership Through €3 Billion Subsidy Dividends

On May 11, Leapmotor (零跑汽车) officially launched an extremely aggressive leasing scheme for the T03 in the German market, with a starting price of just €49 per month. This price is even lower than many mid-to-high-end mobile phone plans in Germany, sending shockwaves through the entry-level electric vehicle (EV) segment.

China's April CPI Rises Moderately to 1.2%; PPI Surges Significantly Driven by International Commodities and Computing Power Demand

On May 11, the National Bureau of Statistics of China released data showing that in April 2026, the national Consumer Price Index (CPI) rose by 1.2% year-on-year, an increase of 0.2 percentage points from the previous month, with the month-on-month figure turning from a decline to a rise. The moderate recovery of the CPI was primarily driven by the dual impact of surging energy prices and an explosion in travel demand during holidays.

ByteDance (字节跳动) Raises 2026 AI Infrastructure Budget to 200 Billion RMB, Accelerating Shift to Domestic Chips to Hedge Supply Chain Risks

On May 9, according to the South China Morning Post citing sources familiar with the matter, ByteDance (字节跳动) has raised its 2026 AI infrastructure capital expenditure plan to 200 billion RMB (approximately $29.4 billion), an increase of at least 25% from the 160 billion RMB scheme drafted at the end of last year.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.